Edward Hospital/Cancer Center
Naperville, Illinois, United States
Cancer treatment center in Naperville, Illinois
120 Spalding Dr #111, Naperville, IL 60540
About Edward Hospital/Cancer Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
35
SWOG Cancer Research Network
24
NSABP Foundation Inc
12
Alliance for Clinical Trials in Oncology
11
NRG Oncology
8
ECOG-ACRIN Cancer Research Group
5
Hoffmann-La Roche
4
ETOP IBCSG Partners Foundation
2
Northwestern University
2
Bristol-Myers Squibb
1
CTI BioPharma
1
Clinical Trials at Edward Hospital/Cancer Center
During the past decade, Edward Hospital/Cancer Center conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 49 clinical trials were completed, i.e. on
average, 125.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 16 clinical trials were completed. i.e. 133.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
1999-07-01
2011-01-01
Completed
1,023
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Edward Hospital/Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 35 trials, followed by "SWOG Cancer Research Network" with 24 trials
sponsored, "NSABP Foundation Inc" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 11 trials sponsored and "NRG Oncology"
with 11 trials sponsored. Other sponsors include 21 different institutions and
companies that sponsored additional 22 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Edward Hospital/Cancer Center"
#1 collaborator was "National Cancer Institute (NCI)" with 59 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "NSABP Foundation Inc" with 6 trials as a collaborator. Other collaborators include 49 different institutions and companies that were
collaborators in the rest 34 trials.
Clinical Trials Conditions at Edward Hospital/Cancer Center
According to Clinical.Site data, the most researched conditions in "Edward Hospital/Cancer Center" are
"Breast Cancer" (22 trials), "Lung Cancer" (5 trials), "Lymphoma" (5 trials), "Recurrent Breast Carcinoma" (5 trials) and "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (5 trials). Many other conditions were trialed in "Edward Hospital/Cancer Center" in a lesser frequency.
Clinical Trials Intervention Types at Edward Hospital/Cancer Center
Most popular intervention types in "Edward Hospital/Cancer Center" are "Drug" (96 trials), "Other" (58 trials), "Biological" (34 trials), "Radiation" (32 trials) and "Procedure" (24 trials). Other intervention types were less common.
The name of intervention was led by "Quality-of-Life Assessment" (26 trials), "Laboratory Biomarker Analysis" (24 trials), "Placebo" (13 trials), "Radiation Therapy" (12 trials) and "Computed Tomography" (11 trials). Other intervention names were less common.
Clinical Trials Genders at Edward Hospital/Cancer Center
The vast majority of trials in "Edward Hospital/Cancer Center" are
83 trials for "All" genders, 27 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Edward Hospital/Cancer Center
Currently, there are NaN active trials in "Edward Hospital/Cancer Center".
undefined are not yet recruiting,
20 are recruiting,
43 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 38 completed trials in Edward Hospital/Cancer Center,
undefined suspended trials,
and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Edward Hospital/Cancer Center, 2 "Phase 1"
clinical trials were conducted, 34 "Phase 2" clinical
trials and 79 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 6 trials that are defined as “Not Applicable".